FindTrial
Sign In

Retrospective Study Based On Antibiotic Consumption And Its Susceptibility In Neonates

Antibiotic Consumption And Its Susceptibility Pattern In Neonates: A Retrospective Study - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/07/071126
Enrollment
384
Registered
2024-07-23
Start date
Unknown
Completion date
Unknown
Last updated
2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: A408- Other streptococcal sepsis

Interventions

Intervention1: NIL: NIL Control Intervention1: NIL: NIL

Sponsors

NIL
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Participants less than 1 month of age who have been admitted in NICU for the following diagnosis, receiving IV antibiotics for a minimum of 5 days Suspected neonatal sepsis Proven or confirmed neonatal sepsis Pneumonia Meningitis Necrotizing enterocolitis Surgical site infection Osteomyelitis Septic arthritis Umbilical sepsis All participants who were treated in the last 2 years (2020- 2021)in Justice KS Hedge Hospital. Participants with clear information and response to antibiotic therapy will be incorporated into the study

Exclusion criteria

Exclusion criteria: Participants who were discharged against medical advice. Participants whose culture sensitivity test is not done

Design outcomes

Primary

MeasureTime frame
To Calculate Antimicrobial Consumption using AMC ToolTimepoint: 8 Months—

Secondary

MeasureTime frame
Choice of empirical antibiotic therapy initiated in participantsTimepoint: 8 months—

Countries

India

Contacts

Public ContactDr Seema Pavaman Sindgikar

NGSM Institute of Pharmaceutical Sciences

udayv@nitte.edu.in8152977460

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026